Jennifer A Kelly Selected Research

Jennifer A Kelly Research Topics

Disease

35	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 10/2006
15	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 02/2008
5	Inflammation (Inflammations) 12/2014 - 01/2010
4	Rheumatoid Arthritis 01/2022 - 03/2017
4	Lupus Nephritis 12/2014 - 04/2009
3	malar rash 01/2012 - 01/2011
2	Genetic Predisposition to Disease (Genetic Predisposition) 12/2015 - 01/2013
2	Lymphopenia (Lymphocytopenia) 01/2013 - 01/2012
2	Proteinuria 01/2012 - 01/2011
2	Nephritis 04/2009 - 02/2003
1	Genetic Risk Score 01/2022
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 04/2019
1	Sepsis (Septicemia) 01/2016
1	Rheumatic Diseases (Rheumatism) 01/2014
1	Disease Susceptibility (Diathesis) 06/2013
1	Oral Ulcer (Mouth Ulcer) 10/2011
1	Exanthema (Rash) 10/2011
1	Seizures (Absence Seizure) 01/2011
1	Hemolytic Anemia 01/2011
1	Arthritis (Polyarthritis) 01/2011
1	Anti-Glomerular Basement Membrane Disease (Goodpasture's Syndrome) 04/2009
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 02/2003
1	Serositis 02/2003
1	Thrombocytopenia (Thrombopenia) 02/2003

Drug/Important Bio-Agent (IBA)

10	AutoantibodiesIBA 01/2022 - 08/2009
6	InterferonsIBA 01/2020 - 04/2011
4	Proteins (Proteins, Gene)FDA Link 11/2020 - 11/2010
4	AntibodiesIBA 11/2020 - 04/2009
4	DNA (Deoxyribonucleic Acid)IBA 01/2015 - 02/2003
3	Interferon-alpha (Interferon Alfa)IBA 01/2020 - 08/2008
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 09/2012
3	Interferon Type IIBA 03/2017 - 01/2010
3	interleukin-21 (interleukin 21)IBA 10/2011 - 08/2009
2	P-2 (P 2)IBA 01/2020 - 02/2008
2	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2017 - 06/2013
2	CytokinesIBA 01/2016 - 01/2013
2	Interleukin-2 (IL2)IBA 09/2011 - 06/2011
1	Ubiquitin-Conjugating EnzymesIBA 01/2022
1	Vitamin D FDA LinkGeneric 01/2022
1	25-hydroxyvitamin DIBA 01/2022
1	hydroxide ionIBA 01/2022
1	CCCTC-Binding FactorIBA 01/2022
1	ChromatinIBA 01/2020
1	Protein Glutamine gamma Glutamyltransferase 2IBA 04/2019
1	Cardiolipins (Cardiolipin)IBA 04/2019
1	Antiviral Agents (Antivirals)IBA 01/2017
1	Nuclear Antigens (Extractable Nuclear Antigens)IBA 01/2016
1	LeptinIBA 12/2015
1	HLA-DR3 Antigen (HLA DR3 Antigen)IBA 12/2014
1	Messenger RNA (mRNA)IBA 12/2014
1	Antigen-Antibody Complex (Immune Complex)IBA 12/2014
1	HLA-DR2 Antigen (HLA DR2 Antigen)IBA 12/2014
1	Toll-Like Receptors (Toll-Like Receptor)IBA 11/2013
1	Mitogen-Activated Protein KinasesIBA 11/2013
1	Biological ProductsIBA 06/2013
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 06/2013
1	NucleolinIBA 01/2013
1	Interleukin-10 (Interleukin 10)IBA 01/2013
1	Nucleic AcidsIBA 01/2013
1	Toll-Like Receptor 7IBA 01/2013
1	Non-Receptor Type 22 Protein Tyrosine PhosphataseIBA 01/2013
1	3' Untranslated Regions (3' UTR)IBA 01/2013
1	AutoantigensIBA 04/2012
1	Complement Factor H (Factor H)IBA 05/2011
1	anti-dsDNA autoantibodyIBA 01/2011
1	HLA-DRB1 Chains (HLA DRB1)IBA 06/2010
1	AntigensIBA 06/2010
1	human MIRN663 microRNAIBA 05/2010
1	MicroRNAs (MicroRNA)IBA 05/2010
1	human MIRN638 microRNAIBA 05/2010
1	Biomarkers (Surrogate Marker)IBA 05/2010
1	interferon kappaIBA 01/2010
1	Interleukin-21 ReceptorsIBA 08/2009
1	Interleukin-1 Receptor-Associated KinasesIBA 04/2009
1	antiglomerular basement membrane antibodyIBA 04/2009
1	Serine (L-Serine)FDA Link 04/2009
1	Kallikreins (Kallikrein)IBA 04/2009
1	EsterasesIBA 04/2009
1	Interferon Regulatory FactorsIBA 08/2008
1	CD11b AntigenIBA 02/2008
1	Genetic Markers (Genetic Marker)IBA 10/2006
1	Antiphospholipid AntibodiesIBA 02/2003

Therapy/Procedure

1	Immunotherapy 01/2015